LUPIN
|
The Current P/B Ratio of LUPIN is 5.04.
| Share Price | ₹2,469.5 | Jul 14,2026 |
| Market Cap | ₹112,903.3 Cr | |
| Book Value | ₹22,384.1 Cr | Mar2026 - Consolidated Results |
| Price/Book | 5.04x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of LUPIN
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹112,903.3 Cr] as on Jul 14,2026
(/) Book Value [ ₹22,384.1 Cr] based on Mar2026 - Consolidated Results
(=) P/B Ratio [ 5.04x ]
Thus, for LUPIN , the investors are currently willing to pay '5.04 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of LUPIN !
The chart below summarizes the trend in P/B Ratio of LUPIN over the last five years.
Historical PB (Price/Book ) ratio chart of LUPIN
PB Ratio Performance Analysis for LUPIN
- LUPIN 's p/b ratio for fiscal years ending Mar2025 to Mar2021 averaged 3.84x.
- LUPIN 's operated at median p/b ratio of 3.4x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, LUPIN 's p/b ratio peaked in Mar2025 at 5.4x.
- LUPIN 's p/b ratio hit its five-year low in Mar2023 of 2.39x.
How does LUPIN 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| LUPIN | 22,384.10 | 5.04 | 112,903.3 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 83,570.10 | 5.57 | 465,507.0 |
| DIVIS LABORATORIES LTD | 16,761.00 | 11.38 | 190,744.0 |
| TORRENT PHARMACEUTICALS LTD | 8,388.43 | 20.06 | 168,250.0 |
| CIPLA LTD | 34,369.40 | 3.38 | 116,213.0 |
| DR REDDYS LABORATORIES LTD | 37,742.60 | 2.75 | 103,980.0 |
| MANKIND PHARMA LTD | 16,252.60 | 6.43 | 104,509.0 |
| ZYDUS LIFESCIENCES LTD | 27,111.40 | 4.17 | 113,102.0 |
| AUROBINDO PHARMA LTD | 37,891.00 | 2.36 | 89,344.7 |
| LAURUS LABS LTD | 5,275.08 | 15.98 | 84,270.8 |
| BIOCON LTD | 34,031.80 | 2.09 | 71,266.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs LUPIN 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 2.09x |
| Max industry PB | 20.06x |
| Median industry PB | 5.04x |
| Average industry PB | 7.20x |
You may also like the below Video Courses